Rating History for Five Prime Therapeutics (FPRX) by Guggenheim

More Stocks Rated by Guggenheim | Latest Ratings for FPRX
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
3/9/2021 Michael Schmidt Downgrade Neutral
(Buy)		 38.00
(N/A)		 37.76
(38.00)		 0.64% Details